The controlled release of therapeutics from microparticles or nanoparticles (NPs) has been well-studied. Incorporation of these particles inside biomaterial scaffolds is promising for tissue regeneration and immune modulation. However, these particles may induce inflammatory and foreign body responses to scaffold constructs, limiting their applications. Here we show that widely used poly(lactic-co-glycolic acid) nanoparticles (PLGA NPs) formed by double emulsion dramatically increased neutrophil infiltration and pro-inflammatory cytokines in alginate scaffolds 1 day after the subcutaneous injection of the scaffolds into mice. The coating of red blood cell (RBC) membranes on PLGA NPs completely eliminated these short-term inflammatory responses. For a longer term of 10 days, neither PLGA NPs nor RBC membrane-coated NPs exerted a significant effect on the infiltration of neutrophils or macrophages in alginate scaffolds, possibly due to the degradation and/or clearance of NPs by infiltrating cells. Despite the extensive exploration of cell membrane-coated NPs, our study is the first to investigate the effects of cell membrane coating on foreign body reaction to NPs. By harnessing the natural biocompatibility of cell membranes, our strategy of anti-inflammatory protection for scaffolds may be pivotal for many applications such as those relying on the recruitment of stem cells and/or progenitor cells to scaffolds.
Introduction
Stem cells and biomaterial scaffolds are two cornerstones of regenerative medicine [1, 2] . Scaffolds that release cytokines, growth factors, and other therapeutics to recruit and modulate cells or control cell microenvironments in situ have attracted increasing attention and are a promising modality for tissue regeneration and immune modulation [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] . One popular strategy to achieve controlled release of Nano Res. 2018, 11 (10) : 5573-5583 therapeutics from scaffolds involves incorporation of therapeutic-encapsulated microparticles or nanoparticles (NPs) into scaffolds [14] [15] [16] [17] . This approach is particularly important when the therapeutics are peptides or small molecules, and scaffold polymers are hydrophilic. Controlled release of relatively small molecules cannot be achieved by entrapping them inside crosslinked hydrophilic polymers. Although it has not been extensively studied, it is known that NPs inside highly biocompatible scaffolds can cause excessive inflammatory responses to scaffold constructs, such as increased neutrophil infiltration [18] . Although an appropriate inflammatory response is necessary for wound healing and may be helpful for stimulating immune responses of scaffold-based vaccines [3, 19] , uncontrolled inflammatory responses should be minimized for general tissue regeneration [20] .
Acute inflammation is the first stage of the foreign body reaction to implanted/injected scaffolds that are recognized as "foreign" by the host immune system. The introduction of scaffolds inside animals or humans results in the immediate adsorption of proteins onto scaffold materials and the subsequent activation of coagulation and complement cascades, which stimulate immune cells [20] [21] [22] [23] . Highly biocompatible materials such as zwitterionic polymers as well as alginate and its derivatives are mostly superhydrophilic with ultralow protein adsorption [24, 25] . In addition to minimizing protein adsorption, scaffolds may be camouflaged to attenuate inflammatory and foreign body responses. Biomaterials cloaked with "self" proteins such as CD200 have shown reduced foreign body reaction [26] , while the modification of materials with peptides binding to Factor H, a soluble complement inhibitory protein, effectively diminished material-induced complement activation [27] .
Recently, cell membrane-coated NPs have emerged as a new class of nanomaterials [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] . Cell membrane coating enables the camouflage of NPs for evading immune clearance and the utilization of natural membrane-bound receptors for active targeting or other applications. Red blood cell (RBC) membranes are rich in "self" protein CD47, which downregulates macrophage phagocytosis via binding to signal regulatory protein alpha on the cells [38] . Cell membrane coating can also lessen complement activation by nanoparticles [29] . We thus hypothesized that an RBC membrane cloak around NPs would attenuate NP-induced inflammatory responses to scaffold constructs. Here, we report the incorporation of doubleemulsion poly(lactic-co-glycolic acid) nano-particles (PLGA NPs), which are widely used for encapsulating cytokines, growth factors, peptides, and hydrophobic drugs, into a macroporous alginate scaffold. PLGA NPs dramatically increased the infiltrated neutrophils and inflammatory cytokines inside scaffolds in vivo (Fig. 1) . This early stage inflammatory response was eliminated after coating PLGA NPs with RBC membranes. Recent studies on cell membrane-coated NPs mostly have focused on targeted delivery, whereas our study is the first to explore the application of cell membrane coating in reducing inflammatory and foreign body responses to NPs.
Experimental

Synthesis of methacrylate-alginate (MA-alginate)
To synthesize MA-alginate, ultra-pure alginate (0.15 g, PRONOVA SLM100) was dissolved in 15 mL deionized (DI) water in a round flask under stirring. After the alginate was fully dissolved, the flask was left in an ice-water bath. Methacrylic anhydride (11.73 g) was added dropwise into the flask, and the solution was stirred vigorously to make the solution homogeneous. 
Preparation of RBC membrane-coated PLGA NPs
A sub-mandibular blood collection method was used to collect blood from C57BL/6J mice (Jackson Laboratory, Bar Harbor, Maine, USA). All animal procedures were conducted according to the protocols approved by the Drexel University Institutional Animal Care and Use Committee in compliance with NIH guidelines. The blood was spun down at 300 × g for 5 min and the plasma and buffy coat were carefully removed. After washing RBCs three times with phosphate-buffered saline (PBS) to remove free proteins, ethylenediaminetetraacetic acid (EDTA) water solution (0.2 mM) was used to rupture RBC membranes and the PBS concentration in the solution was adjusted to 1 × using 10 × PBS (Lonza). The solution was centrifuged at 18,000 × g for 6 min to spin down the membranes, and the supernatant was removed. This process was repeated until the membrane pellet became transparent white in color. To obtain membrane vesicles, membranes in water were sonicated with a probe sonicator at 20% power output for 1 s. One milligram of PLGA NPs were mixed with RBC membrane vesicles from 100 μL of blood. This mixture was incubated overnight at 4 °C to produce RBC membrane-coated PLGA NPs (RBCM-PLGA NPs). RBCM-PLGA NPs were collected by centrifugation at 15,000 × g for 15 min at 4 °C . The supernatant with excess RBC membranes was removed, and the pellet was resuspended in DI water at a concentration of 50 mg/mL for subsequent steps.
Preparation of MA-alginate scaffolds
Macroporous MA-alginate scaffolds were prepared via a cryogelation method, in which MA-alginate was chemically crosslinked at −20 °C [39] . MA-alginate was dissolved in DI water at 1 wt.% and mixed with Nano Res. 2018, 11(10): 5573-5583 0.32 μL of tetramethylethylenediamine (TEMED, Fisher Scientific) for every 50 μL of MA-alginate solution.
The solution was then mixed well with 1.25 μL of 10% ammonium persulfate (APS, Fisher Scientific) aqueous solution. After mixing, the solution was transferred to a 1-mL syringe (BD, USA) and immediately placed in a −20 °C freezer for at least 12 h to form a disc-shaped scaffold. The scaffold was thawed and removed from the syringe and washed in 5 mL of DI water for 1 h to remove the APS and TEMED used for crosslinking. The scaffold was then lyophilized. To load NPs, each scaffold was rehydrated with either 40 μL of PLGA NP solution (50 mg/mL in water) or RBCM-PLGA NP solution (50 mg/mL in water) for 30 min. The scaffolds were then lyophilized again and stored for further studies.
Characterization of NPs and scaffolds
The size and surface potential of PLGA NPs and RBCM-PLGA NPs in water were tested using a Zetasizer Nano ZS (Malvern Instruments, UK). The morphology of particles was observed with transmission electron microscopy (TEM). Samples were prepared as following: plasma was used to clean a carbon film-coated copper grid, and 10 μL of NP solution was dropped on the grid. After 20 min, the grid was washed with 10 μL of DI water 3 times. Five μL of 2% uranyl acetate water solution was put on the grid for 10 s, and a piece of filter paper was used to absorb the stain solution from the grid edge. The grid was air dried and imaged under a JEOL JEM2100 microscope at 200 kV.
To characterize the morphology of scaffolds with confocal microscopy, RBC membrane vesicles were labeled with 1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (ammonium salt) (RhB-DMPE) (Avanti, Alabama), and PLGA NPs were labeled with DiD. Twenty μg of albuminfluorescein isothiocyanate conjugate (FITC-BSA) (Sigma) was added during the scaffold preparation to label the scaffold structure. Scaffolds were rehydrated with DI water and imaged using a laser scanning confocal microscope (Olympus FluoView FV1000).
In vivo cell infiltration study
Female C57BL/6J mice (8-10 weeks of age) were used for the in vivo study. The mice were randomly divided into three groups. Each group of mice was subcutaneously injected with either blank MA-alginate scaffolds, MA-alginate scaffolds with PLGA NPs (PLGA-alginate scaffolds), or MA-alginate scaffolds with RBCM-PLGA NPs (RBCM-PLGA-alginate scaffolds) in saline. Each mouse received two of the same type of scaffolds with one in the left and one in the right flank. After 1 or 10 days, mice from each group were sacrificed, and the scaffolds were harvested. Scaffolds were digested in 1 mL collagenase II (Worthington, NJ) solution at 250 U/mL for 30 min at 37 °C . The scaffolds were mechanically disrupted and filtered through a 70-μm nylon cell strainer (VWR). The collected cells were spun down at 400 × g or 5 min, washed with PBS, and counted using a hemocytometer. For each mouse, 0.25 million cells isolated from two scaffolds were stained for flow cytometry analysis. For staining, cells were first incubated with anti-CD16/32 (BioLegend) for 15 min at 4 °C to block Fc receptors. The cells were then stained with various antibodies, including APC-conjugated CD11c (BioLegend), FITCconjugated F4/80 (BioLegend), and PE-conjugated Ly6G (BioLegend) for 30 min at 4 °C . The stained cells were washed twice with 4% fetal bovine serum in PBS before being characterized via flow cytometry (BD Bioscience). Data were analyzed with FlowJo (Tree Star).
Real-time polymerase chain reaction (PCR) analysis of cytokine expression
Fresh cells isolated from scaffolds were stored in TRIzol (Life Technologies), and RNA from cells was isolated using TRIzol reagent and TURBO DNA-free Kit (Invitrogen) according to manufacturer instructions. The concentration of RNA was quantified using the NanoDrop 1000 Spectrophotomer (Thermo Scientific). cDNA was prepared according to the protocol provided by the High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems). qPCR was carried out using PowerUp SYBR Green Master Mix (Applied Biosystems) on QuantStudio 6 Flex Real-Time PCR System (Applied Biosystems). Primer sequences were as follows: glyceraldehyde-3-phosphate (GAPDH) (F: CCAGAACATCATCCCTGCAT; R: GTTCAGCTCT GGGATGACCTT), interleukin (IL)-10 (F: GCTCTTA Nano Res. 2018, 11(10): 5573-5583 CTGACTGGCATGAG; R: CGCAGCTCTAGGAGC ATGTG), transforming growth factor (TGF)-β (F: CAACCCAGGTCCTTCCTAAA; R: GGAGAGCCC TGGATA CCAAC), tumor necrosis factor (TNF)-α (F: AGGGTCTGGGCCATAGAACT; R: CCACCACGC TCTTCTGTCTAC), and IL-12 (F: GCTTCTCCCACA GGAGGTTT; R: CTAGACAAGGGCATGCTGGT). GAPDH served as an internal control, and all data were normalized to the values of blank MA-alginate scaffolds.
Statistical analysis
Data are presented as mean ± standard deviation (SD) or standard error of the mean (SEM). All the values in the main text indicate mean ± SD unless otherwise specified. Statistical significance between groups was analyzed using Student's t-test (two-sample assuming equal variances), and a value of P < 0.05 is considered as significant.
Results and discussion
Preparation and characterization of PLGA NPs and RBCM-PLGA NPs
We fabricated PLGA NPs following a previously reported double emulsion method [29] . The dynamic light scattering (DLS) results showed an average PLGA NP size of 225 nm (Fig, 2(a) ). RBCM vesicles with an average size of 290 nm were prepared by generating RBC ghosts from the blood of C57BL/6J mice and sonicating them. Incubation of PLGA NPs with RBCM vesicles overnight at 4 °C enabled RBCM vesicles to coat PLGA NPs, forming RBCM-PLGA NPs (Fig. 2(b) ) [32] . The better known physical extrusion method expedites the process of membrane coating around NPs at the cost of reduced yield because a significant amount of NPs are often trapped on filters during extrusion. More recently, cell membrane coating has been achieved by sonicating core NPs and cell membranes simultaneously [40] . Our method minimizes the components for sonication. After the coating step, RBCM-PLGA NPs were centrifuged to remove excess RBC membranes. RBC membrane vesicles without PLGA NPs cores are more difficult to spin down than RBCM-PLGA NPs [34] . By fluorescently labeling both cell membranes and PLGA NPs, we found that more than half of the excess RBC membranes were removed after being centrifuged once, while less than 2% of PLGA NPs were lost. Following preparation, the average size of particles was 247 nm. The coating of RBCM vesicles on PLGA NPs was also reflected in the change in particle surface potential ( Fig. 2(a) ). While PLGA NP had a surface potential of −55 eV due to the terminal carboxylic acid groups, the surface potential of RBCM-PLGA NP (−43 eV) was closer to that of RBCM vesicles (−38 eV). TEM imaging of RBCM-PLGA NPs revealed the core shell structures (Fig. 2(b) ). The size of particles in the TEM image matched well with the result from DLS.
Preparation and characterization of MAalginate scaffolds
Porous scaffolds have broad applications in tissue regeneration and immune cell modulation because connective pores around 100 m or larger allow cell migration into scaffolds. To obtain macroporous scaffolds that can maintain their pore size, MAalginate was used to generate chemically crosslinked alginate. MA-alginate hydrogels have been shown to retain their shapes and macroporous structures after injection [39] . MA-alginate was prepared through the esterification reaction of methacrylic anhydride with hydroxyl groups on alginate (Fig. S1 in the Electronic Supplementary Materials (ESM)). Based on the 1 H NMR (Fig. S2 in ESM) , the degree of substitution was 11%. MA-alginate scaffolds were prepared by crosslinking methacrylate groups of MA-alginate via free radical reaction in the presence of APS and Nano Res. 2018, 11(10): 5573-5583 TEMED. The crosslinking reaction was performed at −20 °C to generate macroporous structures through the formation of ice crystals in the system [39] . The addition of FITC-BSA allowed for the visualization of the interconnected wall structure using confocal microscopy. The average pore size of MA-alginate scaffolds was around 90 μm (Fig. 3) . PLGA NPs and RBCM-PLGA NPs were loaded into scaffolds by rehydrating lyophilized scaffolds with NP solutions, followed by a second lyophilization step to adsorb the particles onto the scaffold walls. For imaging, PLGA NPs were labeled with DiD, while RBCM vesicles were labeled with RhB-DMPE. Figure 3 demonstrates that NPs were successfully loaded into the scaffolds and that the loading of NPs did not change the pore size. NPs were mainly located close to the scaffold frame walls. The high resolution images revealed the colocalization of PLGA NPs and RBCM vesicles, indicating that RBCM vesicles were well coated on PLGA NPs.
In vivo study of short-term cell infiltration in scaffolds
Scaffolds biocompatibility is one of the most important aspects in determining their potential biomedical applications. Scaffolds that cause serious inflammation are unsuitable for many applications, as reactive oxygen species, matrix-degrading enzymes, and inflammatory cytokines damage scaffold-supported cells and tissues surrounding the scaffolds and may induce systemic effects [21, 22] . The immune cells in contact with scaffolds play a major role in initiating inflammation, which includes both short-term and long-term responses. To study the short-term inflammatory responses from scaffolds and NPs, we subcutaneously injected scaffolds into mice and characterized the cells recruited to the scaffolds 1 day later. The total number of cells inside PLGA-alginate and RBCM-PLGA-alginate scaffolds were 1.14 ± 0.24 and 0.93 ± 0.07 million per scaffold, respectively (Fig. 4(a) ). The blank MA-alginate scaffolds showed fewer cells (0.50 ± 0.26 million per scaffold). Alginate is inert and highly biocompatible as reported in many references [39] ; however, the incorporation of NPs increased the number of cells interacting with scaffolds. We identified Representative confocal microscopy images of blank MA-alginate, PLGA-alginate, and RBCM-PLGA-alginate scaffolds. FITC-BSA was added to the MA-alginate solution prior to cryogelation in order to label the scaffold macroporous structure. PLGA NP cores were labeled with DiD, and RBC membranes were labeled with RhB-DMPE. Scale bar for overlay, 200 µm; scale bar for higher magnification, 50 µm. Nano Res. 2018, 11(10): 5573-5583 PLGA-alginate scaffolds. After the introduction of scaffolds into animals or humans, neutrophils are first recruited and are associated with acute inflammation [21, 22] . The addition of PLGA NPs into MA-alginate scaffolds increased the percentage of neutrophils three-fold from 14.96% ± 5.58% to 52.12% ± 8.98% (Fig. 4(c) ), and the absolute number of neutrophils increased five-fold from 0.11 ± 0.08 to 0.58 ± 0.11 million per scaffold. Notably, RBC membrane coating on PLGA NPs eliminated the inflammatory effect of PLGA NPs on neutrophil recruitment, as evident from the decrease in the percentage and absolute number of neutrophils to the levels similar to those observed for blank MA-alginate scaffolds. The existence of PLGA NPs and RBCM-PLGA NPs inside MA alginate scaffolds had no major effects on the DC population. Although the incorporation of either NPs reduced the percentage of DCs by half, the number of DCs remained similar among the three different scaffolds. The addition of PLGA NPs into MA-alginate scaffolds significantly reduced the percentage of monocytes/ macrophages from 44.63% ± 1.65% to 12.7% ± 4.44% and attenuated the cell number from 0.22 ± 0.12 to 0.14 ± 0.04 million per scaffold. The RBC membrane coating of PLGA NPs resulted in an increased percentage of monocytes/macrophages (28.15% ± 1.39%) as well as their cell numbers (0.26 ± 0.04 million per scaffold), bringing the numbers closer to the condition without any NPs. The significantly higher number of neutrophils in the scaffolds with PLGA NPs indicates that PLGA NPs are not as biocompatible as alginate, possibly due to their hydrophobicity that contributes to relatively higher protein adsorption and complement pathway activation. However, coating PLGA NPs with RBC membranes from the same strain of mice was able to camouflage the particles from the immune system and significantly reduced the number of infiltrating neutrophils.
Analysis of cytokine expression by cells in scaffolds
Another indicator of inflammation is the cellular expression of inflammatory cytokines. Therefore, we quantified mRNA transcripts of various cytokines from scaffold cells one day after scaffold injection, including pro-inflammatory cytokines IL-12 and TNF-α and anti-inflammatory cytokines IL-10 and TGF-β. In comparison with the cells from blank MA-alginate Nano Res. 2018, 11(10): 5573-5583 scaffold, those from PLGA-alginate scaffolds showed a three-fold increase in the expression of proinflammatory cytokines IL-12 and TNF-α. On the contrary, cells from RBCM-PLGA-alginate scaffolds showed mRNA expression levels of pro-inflammatory cytokines similar to those observed for cells from blank MA-alginate scaffolds (Fig. 5(a) ). For anti-inflammatory cytokines, cells from PLGA-alginate scaffolds expressed around 50% less IL-10 as compared with cells from the blank MA-alginate scaffolds. On the other hand, IL-10 expression in cells from RBCM-PLGA-alginate scaffolds was approximately 80% of that observed for cells from the blank MA-alginate scaffolds (Fig. 5(b) ).
The expression of TGF-β was similar among all three types of scaffolds ( Fig. 5(b) ). Overall, the incorporation of PLGA NPs into MA-alginate scaffolds significantly increased the expression of pro-inflammatory cytokines, IL-12 and TNF-α, and decreased the expression of anti-inflammatory cytokine, IL-10. However, RBC membrane coating could rescue the cytokine environment by reducing the expression of IL-12 and TNF-α mRNAs to levels similar to those in blank MA-alginate scaffolds and increasing the expression of anti-inflammatory cytokine IL-10 mRNA.
A longer-term in vivo cell infiltration study in scaffolds
We also studied the phenotypes of cells recruited to scaffolds 10 days after scaffold injection. In comparison with the 1-day experiment, the 10-day experiment showed a decrease in the total cell number in all three types of scaffolds, with PLGA-alginate scaffolds exhibiting the highest cell number (0.72 ± 0.13 million per scaffold) and blank MA-alginate scaffolds having the lowest cell number (0.36 ± 0.10 million per scaffold) ( Fig. 6(a) ). The percentage of neutrophils was less than 1%, and their absolute number was less than 10,000 for each of the three types of scaffolds (Figs. 6(b)-6(d) ). The significant decrease in the neutrophil number after 10 days as compared with that observed after 1 day is consistent with the fact that neutrophils are the first cells to migrate to the site of inflammation and that the cell number peaks quickly within 1 or 2 days [21, 22] . In comparison with the 1-day experiment, the 10-day experiment showed a 20%-30% increase in the percentage of macrophages in all three types of scaffolds, with the blank MA-alginate scaffolds exhibiting the highest percentage (64.95% ± 6.53%). The macrophage number was the highest for RBCM-PLGA-alginate scaffolds (0.33 ± 0.03 million per scaffold) and lowest for the blank MA-alginate scaffolds (0.23 ± 0.05 million per scaffold), similar to the result of the 1-day experiment. The percentage of DCs decreased in blank MAalginate scaffolds and remained similar in both PLGA-alginate and RBCM-PLGA-alginate scaffolds. PLGA-alginate scaffolds showed the highest number of DCs (0.08 ± 0.03 million per scaffold) and was similar to that observed in the 1-day experiment. Overall, the number of neutrophils significantly decreased after 10 days as compared with 1 day in all three types of scaffolds, directly resulting in the lower number of total cells. In addition, the number of macrophages was similar in all three scaffolds. The effects to PLGA NPs and RBC membrane coating on cell recruitment diminished after 10 days, likely because the small NPs had degraded or were cleared by recruited cells.
Conclusions
In summary, using PLGA NPs formed by double emulsion as a model particle, we have shown that nanoparticles capable of controlling therapeutic release may induce significant acute inflammatory responses to highly biocompatible scaffolds in vivo upon their incorporation in scaffolds. Coating of RBC membranes around NPs can eliminate the NP-induced short-term inflammatory responses to scaffold constructs, including dramatically increased neutrophil infiltration and pro-inflammatory cytokines. The incorporation of PLGA NPs and RBCM-PLGA NPs did not show an appreciable effect on the number of infiltrated neutrophils or macrophages in alginate scaffolds 10 days after the subcutaneous injection of the scaffolds into mice. This is possibly due to the degradation of NPs or their clearance by infiltrated cells. The protection from cell membrane coating is expected to last longer for microparticles, as larger particles may be more difficult to clear and take a longer time to degrade. Even transient protection can be pivotal because acute inflammatory responses in early stages can alter the recruited cell population and reduce the viability and function of scaffold-seeded or recruited regenerative cells. Therefore, we believe this facile approach to harnessing the natural biocompatibility of cell membranes for reducing inflammatory and foreign body responses may have applications in fields such as tissue regeneration and immune modulation. 
